This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Omeros Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: John Steven Whitaker: Innovator in Antibody Formulations
Introduction
John Steven Whitaker is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. His work focuses on enhancing therapeutic methods to inhibit adverse effects related to complement activation.
Latest Patents
Whitaker holds a patent for "Highly concentrated low viscosity MASP-2 inhibitory antibody formulations, kits, and methods." This invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies. The patent also includes kits comprising these formulations and therapeutic methods for using them to inhibit the adverse effects of MASP-2 dependent complement activation. He has 1 patent to his name.
Career Highlights
Whitaker is currently associated with Omeros Corporation, where he continues to innovate in the field of antibody research. His work has the potential to significantly impact therapeutic approaches in medicine.
Collaborations
Some of his notable coworkers include Gregory A Demopulos and Kenneth M Ferguson. Their collaboration contributes to the advancement of research and development in the biotechnology sector.
Conclusion
John Steven Whitaker's contributions to antibody formulations exemplify the innovative spirit in biotechnology. His work not only enhances therapeutic methods but also showcases the importance of collaboration in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile